This finding suggests the potential utility of PTEN protein expression as a surrogate biomarker to correlate with melanoma’s vertical growth, measured by tumor thickness, which has been shown to greatly affect survival rates in patients [17]. The gene discussed is PTEN; the disease is melanoma.